Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective esketamine dose for opioid-free anesthesia induction during tracheal intubation
ChiCTR2500109751Phase 4Completed
- Sponsor
- Hainan General Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of esketamine in intubation, sponsored by Hainan General Hospital. Primary endpoint: Positive vs negative intubation hemodynamic response count within 2 minutes. Started Sep 2025; status: completed.
02
Drugs
esketamine
03
Conditions
intubation
Beyond the preview
Go deeper on ChiCTR2500109751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109751.